demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID 19 all comersCOVID-19 mild to moderateCOVID-19 severe or critically
COVID 19 hospitalizedCOVID 19 all comersCOVID-19 mild to moderateCOVID-19 severe or critically
miscellaneous
alpha lipoic acid Ming Zhong
Aspirin RECOVERY ...
aviptadil COVID-AIV ACTIV-3 Critical Care
camostat mesilate Gunst JD
Cannabidiol Crippa ...
honey Silveira
povidone-iodine Mohamed
pyridostigmine Fragoso-Saavedra ...
sabizabulin VERU-111

1 studies excluded by filtering options 1

9583 Chow, 2022 0130selection pending